Related Experiment Videos

[Evaluation of cardiovascular risk in the cross-sectional phase of the Mediterranean Study]

V Gil-Guillén1, J Merino-Sánchez, T Sánchez-Ruiz

  • 1REDIAPP-CV. Unidad de Investigación. Docencia y Práctica Clínica. Universidad Miguel Hernández, Elche, Alicante, España. info@sicccro.com

Revista Clinica Espanola
|June 2, 2009
PubMed

Insights

The SCORE scale identifies more high cardiovascular risk (HCR) patients than the REGICOR scale in hypertensive individuals, though consistency between the two risk assessment tools is poor. Significant altered blood pressure and high total cholesterol were observed.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Context:

  • Cardiovascular risk assessment is crucial for preventing heart disease.
  • Existing risk scales like REGICOR and SCORE have varying performance.
  • Hypertension and hypercholesterolemia are significant cardiovascular risk factors.

Purpose:

  • To quantify high cardiovascular risk (HCR) using REGICOR and SCORE scales.
  • To assess the consistency between REGICOR and SCORE in hypertensive and hypercholesterolemic patients.
  • To analyze altered blood pressure (ABP), high total cholesterol (HTC), and cardiac/renal damage in these patient groups.

Summary:

  • The SCORE scale identified more patients with HCR than the REGICOR scale in hypertensive patients (26.1% vs 17.3%) and a similar proportion in hypercholesterolemic patients (21.5% vs 21.1%).
  • Consistency between the REGICOR and SCORE scales was poor (ICC = 0.222 for HT, ICC = 0.190 for HC).
  • Significant prevalence of HTC (64.7%) and ABP (33.7%) was found, along with notable rates of cardiac and renal damage in hypertensive patients.

Impact:

  • Highlights the discrepancies in cardiovascular risk stratification between commonly used scales.
  • Underscores the high prevalence of uncontrolled risk factors and end-organ damage in hypertensive and hypercholesterolemic populations.
  • Informs clinical practice regarding the selection and application of cardiovascular risk assessment tools.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...